Stay updated on PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Sign up to get notified when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T13:25:55.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A banner announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” It does not add information about the clinical trial.
    Difference
    1%
    Check dated 2026-10-24T15:14:23.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.1 to v3.7.2 while the page continued to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-17T15:08:49.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1, while the study page still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:14:36.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    403 Forbidden error is now displayed on the page, replacing the usual study record content. This indicates an access or server issue rather than a content update to the trial information.
    Difference
    18%
    Check dated 2026-09-19T19:05:31.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page revision tag changed from v3.6.5 to v3.6.6, indicating a new version of the page. This update does not alter the study content or related information presented on the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:46:08.000Z thumbnail image

Stay in the know with updates to PROMO: Pembrolizumab in Osteosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the PROMO: Pembrolizumab in Osteosarcoma Clinical Trial page.